Sudarshan Chemical reports strong Q4FY26 performance
Sudarshan Chemical Industries Limited released its Q4FY26 investor presentation, detailing consolidated revenue of ₹2,790 crore and Business EBITDA of ₹247 crore. The company highlighted a 30% QoQ growth in the acquired group's revenue run rate and a significant reduction in net debt to ₹755 crore. Management projects the acquired group's EBITDA to reach €90-100 million over the next 3-4 years.

*this image is generated using AI for illustrative purposes only.
Sudarshan Chemical Industries Limited reported a strong financial performance for the quarter and financial year ended March 31, 2026, with consolidated revenue reaching ₹2,790 crore in Q4FY26. The company announced that its Business EBITDA stood at ₹247 crore for the quarter, driven by a 30% quarter-on-quarter growth in the acquired group's revenue run rate. Net debt reduced significantly from ₹934 crore in December 2025 to ₹755 crore by March 2026.
The company filed the investor presentation with the exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation details the integration progress with Heubach, noting that the combined entity, "One Sudarshan," achieved an annual turnover of approximately €1 billion. Management highlighted that the acquired group's revenue run rate reached €61 million in Q4FY26 compared to €47 million in Q3FY26.
Q4FY26 Performance Highlights
The consolidated results for Q4FY26 show a recovery in sales, supported by increased purchases from Global Key Accounts and demand recovery in key regions like Europe and India. The company reported that inventory reduction efforts exceeded projections, reaching €29 million against a target of €20 million.
| Metric | Q4 FY26 (₹ Cr) | YoY Change |
|---|---|---|
| Revenue from Operations | 2,790 | 6.6% |
| Business EBITDA | 247 | - |
| Business EBITDA % | 8.9% | -0.9pp |
| Adjusted PBT excl. RPS gain | 142 | 239% |
Integration and Outlook
Sudarshan Chemical stated that the integration with Heubach is progressing well, with the SAP S/4 HANA system implementation expected to be fully harmonized by December 2026. The company inaugurated a Global Capability Center (GCC) in Pune to centralize functions. Looking ahead, the management provided a projection for the acquired group, targeting Business EBITDA of €90-100 million over the next 3-4 years, up from €19 million in FY26. For FY27, the group projects sales of approximately €700 million and EBITDA of around €35 million.
Historical Stock Returns for Sudarshan Chemical Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.96% | -0.64% | -2.23% | -12.07% | -29.63% | +27.99% |
What specific strategies will be employed to achieve the targeted €90-100 million Business EBITDA for the acquired group within the next 3-4 years?
How will the completion of the SAP S/4 HANA harmonization in December 2026 impact operational efficiency and cost synergies?
What are the expected revenue contributions from Global Key Accounts and key regions like Europe and India for the upcoming fiscal year?


































